Determinants of postprandial lipemia measured as diurnal triglyceride profile in non diabetic noemolipidemic subjects;Determinantes de la lipemia posprandial medida como perfil diurno de triglicéridos en personas no diabéticas con normolipemia

Medicina Clinica

Volumn 125, Issue 12, 2005, Pages 448-452

  González, Cintia ^a   Real, José T ^a   Bartual, Amadaro ^a   Chaves, Felipe J ^a   García García, Ana B ^a   Blesa, Sebastián ^a   Castro Cabezas, Manuel ^b   Ascaso, Juan F ^a   Carmena, Rafael ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Abdominal fat deposits; Daylong capillarly triglycerides; Insulin resistance; Obesity; Postprandial lipemia

Indexed keywords

INSULIN; TRIACYLGLYCEROL;

ABDOMEN; ADULT; AGE; ARTICLE; BODY FAT; CIRCADIAN RHYTHM; CORRELATION ANALYSIS; DIET RESTRICTION; EVALUATION; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OBESITY; POSTPRANDIAL STATE; PREDICTION; PREMENOPAUSE; REGRESSION ANALYSIS; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 27744463554     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13079610     Document Type: Article

References (31)

1. Ordovás JM, Carmena R. Factures de riesgo cardiovascular. Lipidos plasmáticos y riesgo coronario. En: Carmena R, Ordovás JM. Hiperlipemias: cllnica y tratamiento. Barcelona: Doyma; 1999. p. 173-92.
2. Castro Cabezas M, De Brain TWA, Jansen H, Kock LAW, Kortland W, Erkelens DW. Impaired chylomicron remmants clearance in familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:804-14.
3. Van Oostrom AJ, Van Dijk H, Verseyden C, Sniderman AD, Cianflone K, Rabelin TJ, et al. Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3. Am J Clin Nutr. 2004;79:510-5.
4. Frayn KN. Non-esterified fatty acid metabolism and postprandial lipemia. Atherosclerosis. 1998; 141:541-6.
5. Sniderman AD, Cianflore K. The adipsin acylation stimulating protein pathway and microenviromental metabolic regulation. World Rev Nutr Diet. 1997;80:44-81.
6. Van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, De Konig EJ, Rabelin TJ, et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res. 2003;44:576-83.
7. Wats GF, Mamo JCL. Postprandial dislipidaemia: new opportunities for prevention of coronary disease? Br J Cardiol. 1998;5:260-4.
8. Austin MA, Hokanson JE, Edwards KL. Hypertrigliceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B-12B.
9. Proctor SD, Mamo JCL. Retention of fluorescent labelled chylomicron remmants within the intima of the arterial wall evidence that plaque cholesterol may be derived from postprandial lipoproteins. Eur J Clin Invest. 1998;28:497-503.
10. Hokanson JE, Austin MA. Plasma TG is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol: a meta analyses of population based prospective studies. J Cardiovasc Res. 1996;3:213-9.
11. Criqui MH, Heiss G, Cohn R. Plasma triglyceride level and mortality from cardiovascular disease. N Engl J Med. 1993;328:1220-5.
12. Real JT, Ascaso JF, Carmena R. Insulin resistance and familial combined hyperlipidemia. Cardiovasc Risk Factors. 1999;3:101-6.
13. Castro Cabezas M, Halkes CJM, Meijsson S, Van Oostrom AJHHM, Erkelens DW. Diurnal trigyceride profiles: a novel approach to study triglyceride changes. Atherosclerosis. 2001;155:219-28.
14. Van Oostrom AJ, Castro Cabezas M, Ribalta J, Masana L, Twickler TB, Remjinse TA. Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet. Eur J Clin Invest. 2000;30:964-71.
15. Delawi D, Meijenssen S, Castro Cabezas M. Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controls. Clin Chim Acta. 2003;328:139-45.
16. Halkes CJ, Van Wijk JP, Ribalta J, Masana L, Castro Cabezas M. Diurnal triglyceridaemia and insulin resistance in mildly obese subjects with normal fasting plasma lipids J Intern Med. 2004;255:74-81.
17. Van Oostrom AJ, Real JT, Carmena R, Ascaso JF, Castro Cabezas M. Daylong triglyceridemia in healthy mediterranaen and nothern european subjects. Neth J Med. 2004;62:36-9.
18. Ter Welle HF, Baartscheer T, Fiolet JW. Influence of free glycerol on enzymatic evaluation of triglycerides Clin Chem. 1984;30:1102-3.
19. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583-95.
20. Havel RJ, Eder HJ, Bragdon JH. The distribution and chemical composition of centrifugally separated lipoproteins in human serum. Eur J Clin Invest. 1955;34:1345-53.
21. Rosseneu M, Vercaemst R, Steinberg KK, Cooper GR. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem. 1983;29:427-33.
22. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31:545-8.
23. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatmento of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
24. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999 Jun 10;340:1801-11.
25. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, et al. Clearance of chylomicron remmants in normolipidemic patients with coronary artery disease: case control study over three years. BMJ. 1996;312:935-9.
26. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
27. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 1997;95: 252-64.
28. Blackburn P, Lamarche B, Couillard C, Pascot A, Bergeron N, Prud'homme D, et al. Postprandial hyperlipidemia: another correlate of the «hypertriglyceridemic waist» phenotype in men. Atherosclerosis. 2003;171:327-36.
29. Van Wijk JP, Halkes CJ, Erkelens DW, Castro Cabezas M. Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism. 2003;52:1043-9.
30. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intraabdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087-94.
31. Rubies-Prat J, Pedro-Botet J. Hipertrigliceridemia como factor de riesgo cardiovascular. ¿Fin de la controversia? Med Clin (Barc). 2003;120: 303-7.